Gwirtz K H, Young J V, Byers R S, Alley C, Levin K, Walker S G, Stoelting R K
Department of Anesthesia, Indiana University School of Medicine, Indianapolis, USA.
Anesth Analg. 1999 Mar;88(3):599-604. doi: 10.1097/00000539-199903000-00026.
To assess the efficacy of the analgesic technique and the incidence of complications, we prospectively evaluated patients who received intrathecal opioid analgesia (ITOA) to manage postsurgical pain. Daily quality assurance data were collected on the first postoperative day and tabulated for 5969 adult patients who had received ITOA for major urologic, orthopedic, general/ vascular, thoracic, and nonobstetrical gynecologic surgery. A scale of 1-10 was used to quantify each patient's satisfaction with analgesia. The incidence of side effects, complications, and naloxone usage was also recorded and tabulated. The mean satisfaction score using a 10-point numeric rating scale was 8.51, with a score of 1 connoting "complete dissatisfaction" and 10 connoting "complete satisfaction." Side effects were minor and easily managed. Pruritus was the most common (37%). Respiratory depression was the least common (3%), easily detected by nursing observation, never life-threatening, and always responsive to treatment with naloxone. There were no deaths, nerve injuries, central nervous system infections, or naloxone-related complications. Postdural puncture headaches were rare (0.54%), as was the need for epidural blood patch (0.37%).
Over a 7-yr period, intrathecal opioid analgesia was used to control acute postoperative pain on nearly 6000 patients, resulting in a high degree of patient satisfaction and a low incidence of side effects and complications.
为评估镇痛技术的疗效及并发症发生率,我们对接受鞘内阿片类药物镇痛(ITOA)以控制术后疼痛的患者进行了前瞻性评估。在术后第一天收集每日质量保证数据,并对5969例接受ITOA用于大型泌尿外科、骨科、普通/血管外科、胸科和非产科妇科手术的成年患者的数据进行列表分析。采用1至10分制来量化每位患者对镇痛的满意度。还记录并列表分析了副作用、并发症及纳洛酮使用情况。使用10分数字评分量表得出的平均满意度评分为8.51分,其中1分表示“完全不满意”,10分表示“完全满意”。副作用轻微且易于处理。瘙痒最为常见(37%)。呼吸抑制最不常见(3%),通过护理观察很容易发现,从未危及生命,且总是对纳洛酮治疗有反应。未发生死亡、神经损伤、中枢神经系统感染或与纳洛酮相关的并发症。硬膜穿刺后头痛很少见(0.54%),硬膜外血贴的需求也很少见(0.37%)。
在7年期间,鞘内阿片类药物镇痛被用于控制近6000例患者的急性术后疼痛,患者满意度高,副作用和并发症发生率低。